'Armored' CAR T Cells Show Early Promise in Relapsed B-Cell ALL

(MedPage Today) — At the recent American Society of Hematology annual meeting, phase I data highlighted a next-generation, CD19-targeted, interleukin-18-secreting “armored” CAR T-cell therapy that is designed to enhance persistence and antileukemic…

Source link : https://www.medpagetoday.com/meetingcoverage/ashvideopearlsall/119164

Author :

Publish date : 2025-12-23 17:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

‘Armored’ CAR T Cells Show Early Promise in Relapsed B-Cell ALL

FDA Approves First Oral Medication for Iron Deficiency in Kids

Long-Term Tofersen Use May Slow ALS Progression, 3-Year Data Suggest

Related Posts

How Do Experts Perceive Warning Removal for Menopausal HT?

Former CDC Leaders Offer Alternative ID Surveillance Options

How Weight-Loss Medications Are Changing Hospital Admissions

Risk for Diabetes Rises in Climate-Vulnerable Communities

Alcohol-Related Deaths Rise but Hospitalizations Hold Steady

Simple Strategy Can Slash ED Use in Older Cancer Patients

How Do Experts Perceive Warning Removal for Menopausal HT?

Former CDC Leaders Offer Alternative ID Surveillance Options

How Weight-Loss Medications Are Changing Hospital Admissions

Risk for Diabetes Rises in Climate-Vulnerable Communities

Alcohol-Related Deaths Rise but Hospitalizations Hold Steady

Simple Strategy Can Slash ED Use in Older Cancer Patients

Oral Anticoagulants Raise Abnormal Uterine Bleeding Risk

Do Food Allergies Affect Growth Patterns in Children?

Categories

Archives